Navigation Links
FRC's Jeanne Monahan Responds to Two New Deaths from RU-486
Date:10/1/2010

WASHINGTON, Oct. 1 /PRNewswire-USNewswire/ -- U.S. Centers for Disease Control and Prevention officials have disclosed that two mifepristone (RU-486)-induced deaths occurred in the past two years, bringing the total number of reported death related to RU-486 to 12. This announcement comes almost 10 years to the date after the Food and Drug Administration (FDA) approved the abortion drug, deeming it a major advancement for women's health and safe for public use.

(Logo: http://photos.prnewswire.com/prnh/20080930/FRCLOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20080930/FRCLOGO)

The news came in a letter to the editor of the New England Journal of Medicine on September 30, 2010. Both mifepristone-induced septic shock deaths were caused by c. sordellii, the bacteria linked to a number of RU-486 deaths from 2000-2006.

One woman who died was 29; the other was 21. The deaths occurred in 2008 and 2009, respectively. The public is only now learning of these deaths.

Of this announcement, Family Research Council's Director of the Center for Human Dignity Jeanne Monahan, who formerly worked in the Office of the Secretary in the Department of Health and Human Services, made the following comments:

"Abortion proponents claim that abortions should be 'safe, legal and rare.' Yet RU-486 use is increasing and its safety record is entirely dubious, as these two deaths prove.

"Ten years ago, the FDA's approval process for RU-486 was flawed, relying primarily on French data that the FDA admitted was marked by 'carelessness,' 'fraud,' and 'evidence tampering.' And while the abortion industry achieved a major victory with the approval of RU-486, women have been the victims of the abortion agenda.

"Other drugs with less extreme adverse affects have been pulled from the market quickly, but not RU-486, whose over 1,300 adverse affects on women using the drug – including 336 hospitalizations, 172 blood transfusions, and most gravely, 12 deaths – have been ignored. These two women are just the latest of many to pay a severe price.

"Ten years later, the FDA approved ulipristal acetate – 'ella' – as an emergency contraceptive, despite the fact that it shares an almost identical chemical make-up and identical modes of action with RU-486. Given the strong resemblance, there is reason to believe that the negative side effects will also be similar. Women should not be the 'guinea pigs' of the abortion industry or the government. These risks should not be taken," Monahan concluded.

For more information on RU-486:

FRC Senior Fellow Chris Gacek on the FDA's approval of RU-486: http://www.frc.org/content/politicized-science-the-manipulated-approval-of-ru-486-and-its-dangers-to-womens-health

Jeanne Monahan in Human Events regarding the tenth anniversary of RU-486: http://www.humanevents.com/article.php?id=39179


'/>"/>
SOURCE Family Research Council
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Takeda Responds to Announcement about Suspension of Rosiglitazone Marketing Authorization in Europe and Restrictions in the U.S.
2. Atrium Responds to Bard Suit
3. NVHR Responds to New York Times Article on Hepatitis C Testing
4. Takeda Responds to FDA Advisory Committee Recommendation
5. Coalition for Pulmonary Fibrosis Responds to News of Further Review of Pirfenidone By FDA
6. New Science Education Program Responds to Presidents Call to Help Young People Excel in Science
7. GlaxoSmithKline Responds to US Senate Committee on Finance Report on Avandia
8. U.S. Kidney Dialysis Community Responds to Haitis Emergency Plea for Life-Saving Dialysis Care
9. Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers
10. Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients
11. Endologix Responds to Alleged Patent Infringement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... Site Profile: --> ... The Speech Recognition People, announced their latest primary healthcare case study ... reduce turnaround times and to save the practice money. ... 2013 Challenge: --> ,- Wirral CCG ,- ... Six doctors ,- Wirral CCG ,- VoicePower client since 2013 ...
(Date:2/4/2016)...  The Senior Care Pharmacy Coalition (SCPC) today ... Jason Chaffetz (R-UT) and Ranking Member ... , "Developments in the Prescription Drug Market," to ... about abusive pharmacy benefit manager (PBM) pricing practices. ... Member Elijah Cummings (D-MD) are diligent, serious lawmakers ...
(Date:2/4/2016)... , Feb. 4, 2016  Montoya Love is ... in the field of Pharmaceuticals. Montoya is the Regulatory ... Manufacturing and ... Becton Dickinson provides healthcare institutions, clinical laboratories ... throughout fifty countries across the globe. ...
Breaking Medicine Technology:
(Date:2/8/2016)... CA (PRWEB) , ... February 08, 2016 , ... The ... held annually in this country. The AutismOne 2016 Conference, which is being held May ... they often won’t hear elsewhere about helpful interventions and causes of chronic illness in ...
(Date:2/7/2016)... Scottsdale, AZ (PRWEB) , ... February 07, 2016 ... ... & Neck and Facial Plastics, has added Kybella® to his medical and surgical ... is a newly approved FDA injectable medication used as a non-surgical alternative for ...
(Date:2/6/2016)... ... February 06, 2016 , ... Research ... treatment helps to reduce the frequency and level of relapse. , ... Healthy Identity and Purpose,” will explore the critical tasks of the recovery phase ...
(Date:2/5/2016)... ... 2016 , ... Successful recruitment and retention efforts, new collaborations ... have all marked the last 12 months at Roswell Park Cancer Institute (RPCI). ... oldest cancer center, Candace S. Johnson, PhD, outlined the many accomplishments of her ...
(Date:2/5/2016)... ... February 05, 2016 , ... Freed-Hardeman University President Joe A. ... a joint enrollment and degree completion agreement. The agreement, which begins with ... at FHU|Dickson. , The agreement allows students to be jointly admitted to ...
Breaking Medicine News(10 mins):